Search for Abstracts Find by Title, Author or Description Year Abstracts - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first T01 – Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin Published in 2017 Listed under Poster, T Download Chan Abstract ID: 295 pdf Download Poster (579 KB) T01 – Cisplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery Published in 2016 Listed under T Download Eads T02 – A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After At Least One Prior Regimen for Metastatic Disease Published in 2017 Listed under T Download Chauhan Abstract ID: 250 T02 – A Phase II Trial of LEE011 in Combination with Everolimus in the Treatment of Advanced Well Differentiated Neuroendocrine Tumors of Foregut Origin Published in 2016 Listed under T Download Raj T03 – Pilot Study: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor Published in 2017 Listed under Poster, T Download Hope Abstract ID: 309 pdf Download Poster (671 KB) T03 – SPINET: A Randomized, Double-blind, Placebo-controlled Phase III Study of Lanreotide Autogel/Depot (LAN) in Patients with Advanced Lung Neuroendocrine Tumors Published in 2016 Listed under Poster, T Download Reidy-Lagunes pdf Download Poster (804 KB) T04 – Multicenter Phase 2 Study of Nintedanib in Patients (pts) with Advanced Progressing Carcinoid Tumors Published in 2017 Listed under T Download Iyer Abstract ID: 288 T05 – Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of 177Lu-OPS201 as Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors Published in 2017 Listed under Poster, T Download Nicolas Abstract ID: 285 pdf Download Poster (849 KB) T06 – Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET) Published in 2017 Listed under Poster, T Download Soulen Abstract ID: 311 pdf Download Poster (475 KB) T07 – ElevatION:NET-201 An Open-Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-Differentiated, Non-Functional NET of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-Differen Published in 2017 Listed under Poster, T Download Yao Abstract ID: 242 pdf Download Poster (848 KB) T1 - A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After at Least One Prior Regimen for Metastatic Disease Published in 2018 Listed under Poster, T Download Abstract ID: 81 Aman Chauhan, Susanne Arnold, Stacey Slone, Emily Dressler, Lowell Anthony pdf Download Poster (495 KB) T2 - A Pilot Study of Pembrolizumab and Liver-Directed Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Liver Metastases Published in 2018 Listed under Poster, T Download Abstract ID: 110 Nicholas Fidelman Emily Bergsland Lawrence Fong pdf Download Poster (246 KB) T3 - Pembrolizumab-Based Therapy in Previously Treated High Grade Extrapulmonary Neuroendocrine Carcinomas Published in 2018 Listed under Poster, T Download Abstract ID: 96 Claire K. Mulvey, Claire Hooker, Jennifer A. Chan, Rahul Raj Aggarwal, Pelin Cinar, Thomas A. Hope, K. Pallav Kolli, Li Zhang, Susan Calabrese, Jennifer A. Grabowsky, Diane Reidy-Lagunes, Lawrence Fong, Nitya Prabhakar Raj, Emily K. Bergsland pdf (2.24 MB) pdf Download Poster (2.24 MB) T4 - A Pilot Phase 2 Study of Albumin-Bound Rapamycin Nanoparticles, ABI-009, in Patients with Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors (NETs) of the Lung or Gastroenteropancreatic System Published in 2018 Listed under Poster, T Download Abstract ID: 63 Robert A. Ramirez, Marc Matrana, Suma Satti, Ryan P. Griffin, Ramcharan Thiagarajan, J. Philip Boudreaux, Eugene A. Woltering pdf Download Poster (385 KB) 5 10 15 20 25 30 50 100